Indivior stock stands at USD 34.88 below analyst targets
Published on 09/22/2026 at 14:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Indivior stock traded at USD 34.88 on the Nasdaq on September 20, 2026, while the average 12-month analyst target stood at USD 45.17. The gap of USD 10.29 gives the valuation discussion a concrete benchmark for investors.
Target gap reaches USD 10.29
According to IT BOLTWISE on September 20, 2026, Indivior was quoted at USD 34.88 and the average analyst target was USD 45.17. The implied difference is USD 10.29, or 29.5 percent of the quoted share price.
The same September 20, 2026 assessment also cited an extended target band near USD 49.00. That places the upper reference roughly USD 14.12 above the quoted price, making the spread between market valuation and published expectations the central measurable point.
Market value reaches USD 4.4 billion
The September 20, 2026 market data placed Indivior's market capitalization at about USD 4.4 billion. Together with the USD 34.88 Nasdaq price, the figures describe a company that remains valued below the published average target despite its established market capitalization.
The comparison is not a forecast. It shows only the distance between a dated market quotation and a dated analyst benchmark. The USD 45.17 average target and the target band near USD 49.00 are external reference values, while the USD 34.88 quote is the observed Nasdaq price for September 20, 2026.
Stock valuation remains the key measure
For investors, the relevant calculation is therefore the USD 10.29 spread rather than the target alone. A market price of USD 34.88 against an average target of USD 45.17 creates a 29.5 percent difference, while the cited market capitalization was about USD 4.4 billion on September 20, 2026.
Indivior stock closed the available dated comparison at USD 34.88 on the Nasdaq on September 20, 2026. The fact box records the same reference price and date.
Indivior stock facts
- Company: Indivior plc
- ISIN: GB00BYZ0C031
- Ticker: INDV
- Trading venue: Nasdaq
- Price as of September 20, 2026: USD 34.88
- Market capitalization: USD 4.4 billion (as of September 20, 2026)
- Sector / Industry: Health Care / Pharmaceuticals
